Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

VIP Dx XMRV Test discontinued

Discussion in 'XMRV Testing, Treatment and Transmission' started by Ana, Sep 29, 2011.

  1. ukxmrv

    ukxmrv Senior Member

    I don't think that the name matters Firestormm.

    Originally it was just XMRV but after the Alter Lo paper it was extended to other related RV's (MLV's and HGRV's)

    A patient with HIV was just as sick when they were told that they had LAV or HTLV and all the other names.

    Over time the WPI will sequence them all and then names will be agreed for all the viruses they have found. I'm happy to wait until then.
  2. Firestormm

    Firestormm Guest

    Cornwall England
    Thanks for replying.

    Yeah I guess it will take another published paper to support the claims being made now. I mean Lombardi was 'XMRV' wasn't it? So presumably the title at least is now up for debate.

    I really hope that Dr Mikovits et al. can produce another research paper, peer reviewed and published that confirms whether or not a retrovirus (whatever it is called) is present in patient blood (and/or tissue).

    The BWG concluded that they couldn't find XMRV/MLVs in the samples - so if the claims stand up to scrutiny that another (or similar strain) of retrovirus accounts for the 'tests' being 'positive' then surely it will not take much to provide evidence?

    Anyway, thanks for replying.

See more popular forum discussions.

Share This Page